Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
copper (cu-7) (5 trials)
dpc (1 trial)
Amyotrophic Lateral Sclerosis (Phase 3)
Motor Neuron Disease (Phase 3)
Parkinson Disease (Phase 1)
Sclerosis (Phase 3)
Trials (6 total)
Trial APIs (2 total)